Biotechnology Obesity Solutions Like Weight Loss Drugs To Act As Catalyst For Economic Surge, Goldman Sachs Forecasts – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Novo Nordisk’s Weight Loss Drugs Ozempic, Wegovy Show Promise For Diabetic Patients Undergoing Hip Replacement – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs – Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY) Read more
Biotechnology Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand – Catalent (NYSE:CTLT), Novo Nordisk (NYSE:NVO) Read more
Opinion Thinking about buying stock in NKGen Biotech, Novo Nordisk, SoundHound AI, Safety Shot, or Energy Fuels? – NKGen Biotech (NASDAQ:NKGN), Novo Nordisk (NYSE:NVO) Read more
Opinion Thinking about trading options or stock in Stryker, Meta Platforms, PayPal, Novo Nordisk, or Schlumberger? – Meta Platforms (NASDAQ:META), Novo Nordisk (NYSE:NVO) Read more
Biotechnology With Bumper $33B Sales, Novo Nordisk Forecasts Double-Digit 2024 Earnings Growth, Boosts Lower Dose Wegovy US Supplies – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Novo Nordisk Skyrockets To $506B Valuation Driven By ‘Miracle’ Drugs Ozempic, Wegovy – Novo Nordisk (NYSE:NVO) Read more